Showing results (201-210 of 651) with videos related to
Sort By:
Pageof 66
Diabetologia|December 20, 2019
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)John B Buse, Deborah J Wexler, Apostolos Tsapas, et al.Cardiovascular Diabetology|September 1, 2019
Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetesRegitse H Christensen, Bernt Johan von Scholten, Christian S Hansen, et al.International Journal of Cardiology|May 13, 2019
An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetesPeter G Jørgensen, Morten Schou, Tor Biering-Sørensen, et al.Diabetologia|July 28, 2014
Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up studyJakob A Østergaard, Steffen Thiel, Peter Hovind, et al.Diabetes|August 9, 2012
Urinary proteomics for early diagnosis in diabetic nephropathyPetra Zürbig, George Jerums, Peter Hovind, et al.BMJ Open Diabetes Research & Care|July 10, 2026
Prevalence, incidence, mortality, and years of life lost to diabetes from 1996 to 2024 in DenmarkRasmus Wibaek, Vanja Kosjerina, Stine Byberg, et al.Journal of Diabetes and Its Complications|August 31, 2020
Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortalitySidar Copur, Emine M Onal, Baris Afsar, et al.European Journal of Endocrinology|March 27, 2020
Cardiovascular prognostic value of echocardiography and N terminal pro B-type natriuretic peptide in type 1 diabetes: the Thousand & 1 StudyRasmus Rørth, Peter Godsk Jørgensen, Henrik Ullits Andersen, et al.Diabetes Care|December 21, 2019
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)John B Buse, Deborah J Wexler, Apostolos Tsapas, et al.Diabetes, Obesity & Metabolism|January 21, 2017
Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trialBernt Johan von Scholten, Frederik Persson, Signe Rosenlund, et al.Pageof 66